NOVOZYMES A/S: cashflow_financing

Value{"amount": -1889000000.0, "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities"}
Period2023-01-01 – 2023-12-31
Statuscurrent
EntityNOVOZYMES A/S
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:529900T6WNZXD2R3JW38:2023-12-31
Retrieved: 2026-08-23T23:50:02.590649+02:00
Raw response sha256: 6155c534b334fafbbfc9db117d357491…
Cite as: FACTANKER, https://factanker.com/fact/f6b343e4-ac65-4cf3-a4cd-593e9448e4dd

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies